Rotavirus
Australian health officials recently announced that a new infant rotavirus vaccine has been successful in preventing rotavirus and non-rotavirus acute gastroenteritis hospitalizations in vaccinated children and older individuals who are unvaccinated.
Rotavirus
Researchers in Asia and Africa said this week that trials have shown rotavirus vaccines can save the lives of young children and that vaccination programs should begin immediately.
Rotavirus
Florida researchers have announced the results of an investigation into the effectiveness of two Rotavirus vaccines in a retrospective study that shows the vaccines may have resulted in fewer hospitalizations.
Rotavirus
The U.S. Food and Drug Administration says two vaccines created to combat rotavirus are safe to use despite the presence of a pig virus found in each.
Officials from the Food and Drug Administration are advising that doctors should temporarily stop using the vaccine against a diarrhea-causing virus because the vaccine is contaminated with an apparently harmless pig virus.
Rotavirus
WASHINGTON — A vaccination campaign to combat rotavirus in the world's poorest countries could save the lives of hundreds of thousands of children, according to a pair of studies published this week.
Rotavirus
A complete three-dose series of pentavalent rotavirus vaccine was 85 percent to 89 percent effective against rotavirus gastroenteritis severe enough to cause emergency room visits or hospital admission in children aged 15 days through 23 months.
Rotavirus
Rotavirus is responsible for the deaths of more than 1,500 infants and children daily, mainly in developing countries. The International Medica Foundation is sponsoring a Phase II clinical trial of its oral rotavirus vaccine, RotaShield.
World Health Organization
DAKAR, Senegal — Health experts in Africa are calling on governments to vaccinate children against rotavirus, to end an “unacceptable” yet preventable situation in which the virus kills some 1,400 children in developing countries daily
GlaxoSmithKline announced Nov. 30 that it has filed its vaccine for the prevention of rotavirus gastroenteritis (approved as Rotarix in several countries outside of Japan).
